Literature DB >> 10756213

Mechanisms of eosinophil-associated inflammation.

G J Gleich1.   

Abstract

Increasing evidence supports a critical role for the eosinophil in disease. Here, the mechanisms underlying eosinophil-associated inflammation are reviewed including eosinophil constituents, eosinophil maturation and release from the bone marrow, and eosinophil tissue recruitment and activation. Eosinophil effector functions in bronchial asthma are summarized with particular attention to pulmonary M2 muscarinic receptors and bronchial hyperreactivity. Recent findings supporting roles for IL-5, the eosinophil, and its ribonucleases in viral immunity are presented. Overall, this information supports an expanded view of eosinophil participation in health and disease.

Entities:  

Mesh:

Year:  2000        PMID: 10756213     DOI: 10.1067/mai.2000.105712

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  160 in total

1.  Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G.

Authors:  M H Shin; H Kita; H Y Park; J Y Seoh
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

Review 3.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

Review 4.  Eosinophils: important players in humoral immunity.

Authors:  C Berek
Journal:  Clin Exp Immunol       Date:  2015-09-28       Impact factor: 4.330

5.  rhEPO (recombinant human eosinophil peroxidase): expression in Pichia pastoris and biochemical characterization.

Authors:  Chiara Ciaccio; Alessandra Gambacurta; Giampiero De Sanctis; Domenico Spagnolo; Christina Sakarikou; Giovanni Petrella; Massimo Coletta
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

6.  Activated human eosinophils.

Authors:  Rossana C N Melo; Peter F Weller; Ann M Dvorak
Journal:  Int Arch Allergy Immunol       Date:  2005-10-24       Impact factor: 2.749

7.  Löffler endocarditis without peripheral eosinophilia.

Authors:  G H Wasmeier; D Ropers; A Dimmler; T Fischlein; W G Daniel
Journal:  Clin Res Cardiol       Date:  2007-01-22       Impact factor: 5.460

8.  Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma.

Authors:  Riaz I Zuberi; Daniel K Hsu; Omer Kalayci; Huan-Yuan Chen; Holly K Sheldon; Lan Yu; John R Apgar; Toshiaki Kawakami; Craig M Lilly; Fu-Tong Liu
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Generation of IL10 and TGFB1 coexpressed mice displaying resistance to ovalbumin-induced asthma.

Authors:  Fei Xu; Xiuhua Kang; Liang Chen; Chuanhui Chen; Gen Hu; Wei Bai; Wei Zhang
Journal:  Transgenic Res       Date:  2016-10-01       Impact factor: 2.788

10.  A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

Authors:  Karl Ziegelbauer; Florian Gantner; Nicholas W Lukacs; Aaron Berlin; Kinji Fuchikami; Toshiro Niki; Katsuya Sakai; Hisayo Inbe; Keisuke Takeshita; Mina Ishimori; Hiroshi Komura; Toshiki Murata; Timothy Lowinger; Kevin B Bacon
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.